Avoid initial public offerings of companies saddled with debt, especially if the debt is caused by special-dividend payouts to private equity firms. Read More

Selling stock short can be hazardous to your wealth, even when a company's financials continue to struggle. The name of the game is not absolute financial performance, but the relationship of actual performance to investor expectations. Case in point: Strayer Education. Read More

Two things are working in the stock market right now: momentum stocks of any type and value stocks that are cheap and ripe for a takeover bid. Read More

Increased healthcare spending is a macrotrend, especially increased female healthcare spending. A small-cap company with a Buffett-style value philosophy is an exciting and profitable way to play this. Read More

China's economic weakness and currency devaluation may cause the Federal Reserve to delay its first interest-rate hike, which could spur a short-term rally into September. A subsequent washout low in October would set up the next bull run for small caps into 2016. Stay in momentum stocks until the smoke clears. Read More

Initial public offerings (IPOs) can be exciting growth investments, but sometimes investors are better off letting the IPO train leave the station without them. Read More

Animal health is a booming business. With M&A activity in the space heating up, companies like VCA and IDEXX are takeover candidates. Read More

Momentum stocks like China Biologic are the place to be, but also keep your eye on takeover candidates among value stocks like Lattice Semiconductor. Read More